NCT04656119View on ClinicalTrials.gov

Discovery of Biomarkers Related to the Efficacy and Adverse Reactions of Immune Checkpoint Inhibitors Based on Metabolism-genomics

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

November 3, 2020

Primary Completion Date

November 3, 2022

Study Completion Date

November 3, 2025

Conditions

Cancer

Interventions

OTHER

there is no intervention in our study

there is no intervention in our study

Trial Locations (1)

100027

RECRUITING

Beijing Chao-yang Hospital, Beijing

All Listed Sponsors

lead

Beijing Chao Yang Hospital

OTHER